First Drug for Desmoid Tumors: 'Impressive' Data for Nirogacestat
Nirogacestat showed improved progression-free survival, pain scores, symptoms, and quality of life in patients with progressive desmoid tumors in a phase 3 trial hailed as 'practice changing.'
Medscape Medical News
source https://www.medscape.com/viewarticle/980544?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/980544?src=rss
Comments
Post a Comment